Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
2014 UPDATES
Find the latest in:
CLSI Consensus-based Standards and Guidelines
Companion Products and Subscription Offerings
Educational Resources and Training Opportunities
MEMBERSHIP
The Benefits
Access CLSIs complete library of standards at
discounts of up to 70% o!
Facilitate accreditation preparedness and speed
development of standard operating procedures.
Earn convenient and cost-eective continuing
education credits through CLSI Us education
programs.
Collaborate with colleagues to create and
influence the standards that impact the work you
do each day.
Raise your laboratorys visibility and gain
recognition among our member organizations.
*Industry members receive additional benefits in each category to meet
their more robust business needs. Visit www.clsi.org/membership for more
information.
Network With
1,600+
Organizations
in the Global
Laboratory Community
Actively Collaborate
on CLSI Standards
Development
Receive Up to
70%
Savings on CLSI
Products and
Programs
Organizational Membership*
Discover how our three comprehensive levels of membership can meet the needs of
your facility and budget.
Level I Membership
Benefits include:
CLSIs complete library of
standards, online and on
CD-ROM
A 70% discount on other
CLSI products and programs
II
Level II Membership
Benefits include:
A subscription to all newly
published and revised
standards delivered straight
to your inbox as soon as they
are published
III
Level III Membership
Benefits include:
A 50% discount on CLSI
standards, products,
and programs
Individual Membership
An aordable option for anyone who is interested in supporting or volunteering for CLSI,
regardless of employer aliation
Full Member
Associate Member
Benefits include:
Benefits include:
Student Member
Featured Products
Quality System Regulation for Laboratory Developed Tests: A Practical Guide for the Laboratory. . . . . . . . 2
EP23 Online Workshop: Risk-Based Tools to Meet IQCP Requirements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
StatisPro . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
CLSI Communities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Infobase 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
eM100. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
eCLIPSE Ultimate Access . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
CLSI Crosswalks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
The Key to Quality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
LQMS Certificate Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Implementing the Cost of Quality in the Laboratory Certificate Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Webinars . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Order Form . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
COMING SOON!
CLSI Standards
CLSI standards are built on the expertise of and consensus achieved by government,
industry, and laboratory health care professionals to yield highly respected best
practices for continually improving quality, safety, and efficiency in laboratory testing
and reporting.
AUTO11-A2
OCTOBER 2014
October 2014
AUTO11-A2
This document provides a framework for communication of information technology security issues
between the in vitro diagnostic system vendor and the health care organization.
C56-A QG
Examples of Hemolyzed, Icteric, and Lipemic/Turbid Samples Quick Guide
This Quick Guide shows examples of hemolyzed, icteric, and lipemic/turbid samples, including
the sample appearance and interfering substance (influence quantity). Formatted as a durable,
waterproof sheet for quick reference.
C57-A
COMING SOON
January 2015
C57-A
Mass Spectrometry for Androgen and
Estrogen Measurements in Serum;
Approved Guideline
This guideline is intended to aid the laboratorian in developing appropriate procedures for the use of
mass spectrometry in the measurement of androgens and estrogens.
C62-A
OCTOBER 2014
October 2014
C62-A
Liquid Chromatography-Mass Spectrometry
Methods; Approved Guideline
This document provides guidance to the clinical laboratorian for the reduction of interlaboratory
variance and the evaluation of interferences, assay performance, and other pertinent characteristics of
clinical assays. This guideline emphasizes particular areas related to assay development and presents a
standardized approach for method verification that is specific to mass spectrometry technology.
GP23-A2
NOVEMBER 2014
November 2014
GP23-A2
Nongynecological Cytology Specimens:
Preexamination, Examination, and
Postexamination Processes; Approved
GuidelineSecond Edition
GP36-A
NOVEMBER 2014
November 2014
GP36-A
Planning for Laboratory Operations During
a Disaster; Approved Guideline
This document provides guidance for laboratory and health care leadership for development,
implementation, and sustainment of eective, all hazards, emergency preparedness plans supporting
nonanalytical components of clinical and public health laboratory services that may pertain to various
natural and manmade disasters. It focuses on operational, preexamination functions.
I/LA28-A2 QG
Comparison of the Characteristics of Immunoassays Such as Enzyme-Linked
Immunosorbent Assay and Immunohistochemistry Quick Guide
This Quick Guide compares the characteristics of immunoassays and immunohistochemistry,
such as indications for use, specimen sampling distribution, detection methodology, and
interpretation of the analytical result. Formatted as four durable, waterproof sheets for quick
reference.
EP05-A3
OCTOBER 2014
October 2014
EP05-A3
Evaluation of Precision of Quantitative
Measurement Procedures; Approved
GuidelineThird Edition
This document provides guidance for evaluating the precision performance of quantitative
measurement procedures. It is intended for manufacturers of quantitative measurement procedures
and for laboratories that develop or modify such procedures.
EP15-A3
SEPTEMBER 2014
September 2014
EP15-A3
User Verification of Precision and Estimation
of Bias; Approved GuidelineThird Edition
This document describes the estimation of imprecision and of bias for clinical laboratory quantitative
measurement procedures using a protocol that can be completed within as few as five days.
EP14-A3
AUGUST 2014
August 2014
EP14-A3
Evaluation of Commutability of
Processed Samples; Approved Guideline
Third Edition
This document provides guidance for evaluating the commutability of processed samples by
determining if they behave dierently than unprocessed patient samples when two quantitative
measurement procedures are compared.
1,800+
ACTIVE VOLUNTEERS
collaborate in the development of
CLSI standards and guidelines.
Get Involved
Volunteer Today!
EP23-A
TM
October 2011
EP23-A TM
A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.
Use CLSIs approved guideline for laboratory QC based on risk management to:
Reduce risk through a comprehensive QC plan.
Whats New
in Version 3.0?
Version 3.0 has multiple
enhancements, including:
Implementation of CLSI
document EP09-A3
Deming regression
Passing-Bablok regression
Bias plots
Implementation of CLSI
document EP17-A2
Improvements to study
design to match new
guidelines
Limit of detection and
limit of quantitation
estimation from the
precision profile approach
Try a FREE 30-day trial and discover how this software can transform
your method evaluation protocols for greater time and cost savings.
Visit www.statispro.org to obtain the trial oer.
CLSI membership discounts do not apply to StatisPro.
January 2015
M100-S25
Performance Standards for Antimicrobial
Susceptibility Testing; Twenty-Fifth
Informational Supplement
M100-S25
january 2015
New or revised interpretive criteria are available for the following drugs:
New azithromycin disk diusion and
minimal inhibitory concentration
interpretive criteria for Salmonella typhi
Added:
Information about an epidemiological
cuto value (ECV) established
for Propionibacterium acnes with
vancomycin and how ECVs are used
New table with ECV values for
vancomycin when considering therapy for
a P. acnes infection with information on
how this ECV should be used
M02-A12 PK
January 2015
M02-A12
Performance Standards for Antimicrobial
Disk Susceptibility Tests; Approved
Standard Twelfth Edition
JANUARY 2015
This document contains the current CLSI-recommended methods for disk susceptibility testing,
criteria for quality control testing, and updated tables for interpretive zone diameters.
M07-A10 PK
January 2015
M07-A10
Methods for Dilution Antimicrobial
Susceptibility Tests for Bacteria That Grow
Aerobically; Approved StandardTenth
Edition
JANUARY 2015
This document addresses reference methods for the determination of minimal inhibitory
concentrations of aerobic bacteria by broth macrodilution, broth microdilution, and agar dilution.
M02-A12/M07-A10 PK15
BUNDLE
M100-S25 is available only with the purchase of M02-A12, M07-A10, or
AND SAVE! both
documents.
Collection includes:
M02-A12Performance Standards for
Antimicrobial Disk Susceptibility Tests; Approved
StandardTwelfth Edition
M07-A10Methods for Dilution Antimicrobial
Susceptibility Tests for Bacteria That Grow
Aerobically; Approved StandardTenth Edition
Quality Management
Systems
Method Evaluation
Coming Soon!
Membership
Microbiology
Newborn
Screening
Communities
Participate in CLSIs online Communities to collaborate with
fellow professionals!
Share your knowledge and disseminate
information.
M29-A4
MAY 2014
May 2014
M29-A4
Protection of Laboratory Workers From
Occupationally Acquired Infections;
Approved GuidelineFourth Edition
Based on US regulations, this document provides guidance on the risk of transmission of infectious
agents by aerosols, droplets, blood, and body substances in a laboratory setting; specific precautions
for preventing the laboratory transmission of microbial infection from laboratory instruments and
materials; and recommendations for the management of exposure to infectious agents.
M39-A4 QG
Collection, Handling, Transport, and Storage for Hemostasis Antibiograms: Developing
Cumulative Reports for Your Clinicians Quick Guide
Based on M39-A4, this Quick Guide serves as a handy reference for laboratory personnel. It
provides recommendations for preparation of a cumulative antibiogram, examples of selection
criteria, and supplemental analyses. It also shows how to prepare tables, include a description
of limitations of data, and provide examples of reports and graphs. Formatted as seven durable,
waterproof sheets on a convenient detachable ring.
M40-A2
JUNE 2014
June 2014
M40-A2
Quality Control of Microbiological
Transport Systems; Approved Standard
Second Edition
This document provides criteria to assist manufacturers and end users of transport devices in providing
and selecting dependable products for the transport of microbiological clinical specimens.
M56-A
JULY 2014
July 2014
M56-A
Principles and Procedures for Detection of
Anaerobes in Clinical Specimens; Approved
Guideline
This document presents standardized, cost-eective, and ecient best practice processes for
anaerobe bacteriology to assist clinical laboratories in selecting those methods that lead to improved
patient care.
MM03-R3
COMING SOON!
January 2015
MM03-R3
Molecular Diagnostic Methods for
Infectious Diseases; A Report
This document addresses topics relating to clinical applications, amplified and nonamplified nucleic acid
methods, selection and qualification of nucleic acid sequences, establishment and evaluation of test
performance characteristics, inhibitors, and interfering substances, controlling false-positive reactions,
reporting and interpretation of results, quality assurance, regulatory issues, and recommendations for
manufacturers and clinical laboratories.
November 2013
I/LA26-A2
January 2015
M100-S25
Performance Standards for Antimicrobial
Susceptibility Testing; Twenty-Fifth
Informational Supplement
Our user-friendly, searchable CD-ROM includes all documents published through December 31, 2014.
13
M100-S25
This online implementation of CLSIs most widely recognized antimicrobial susceptibility testing (AST) document
provides information for drug selection, interpretation, and quality control as well as the latest recommendations for
detecting resistance mechanisms, all arranged in an easy-to-use, interactive, and searchable format.
Quickly access M100-S25 information in the laboratory
all you need is a Web connection.
eM100 Basic
eM100 Full
Members: LI$150, LII$200, LIII$250
e CLIPSE
TM
Ultimate Access
Subscribe Today!
Call 610.688.0100 to Unlock Your
Ultimate Access.
E-mail: customerservice@clsi.org |
Visit: www.clsi.org
CLSI-FDARecognized
Consensus Standards
15
NBS01-A6 DVD
JUNE 2014
NEWBORN
SCREENING
POCT04-A3
COMING SOON
January 2015
POCT04-A3
Essential Tools for Implementation and
Management of a Point-of-Care Testing
Program; Approved GuidelineThird
Edition
Essential Tools for Implementation and Management of a Pointof-Care Testing Program; Approved GuidelineThird Edition
This document provides guidance to users of in vitro diagnostic devices outside the clinical laboratory in
order to ensure reliable results comparable to those obtained within the clinical laboratory.
POCT13-A3
COMING SOON
January 2015
POCT13-A3
Glucose Monitoring in Settings Without
Laboratory Support; Approved Guideline
Third Edition
This document contains guidelines for performance of point-of-care glucose monitoring systems that
stress quality control, training, and administrative responsibility.
17
TM
By using the guidance and tools in The Key to Quality, you can:
Improve patient care.
Reduce risk of medical
errors.
Streamline laboratory
processes.
Improve customer
satisfaction.
Reduce costs.
QMS20-R
May 2014
QMS20-R
MAY 2014
19
Now Available!
QMS11-A2
COMING SOON
January 2015
QMS11-A2
Grounded in the principles of quality management and patient safety, this guideline provides an
outline and content for developing a program to manage a medical laboratorys nonconforming events.
QMS18-A
COMING SOON
January 2015
QMS18-A
Process Management; Approved Guideline
This guideline describes four requirements for managing laboratory processes and provides suggestions
for eectively meeting regulatory and accreditation requirements, optimizing ecient use of resources,
and contributing to patient safety and positive outcomes.
21
VET04-A2 PK
BUNDLE
AND SAVE! Members LI: $54 LII: $72 LIII: $90
Nonmembers $180
VET04-A2
September 2014
VET04-A2
Methods for Broth Dilution Susceptibility
Testing of Bacteria Isolated From Aquatic
Animals; Approved GuidelineSecond
Edition
SEPTEMBER 2014
This document provides the most up-to-date techniques for the determination of minimal
inhibitory concentrations of aquatic bacteria by broth micro- and macrodilution, and criteria for
data interpretation and quality control testing.
VET03/VET04-S2
September 2014
VET03/VET04-S2
Performance Standards for Antimicrobial
Susceptibility Testing of Bacteria
Isolated From Aquatic Animals; Second
Informational Supplement
SEPTEMBER 2014
This document provides updated tables for the CLSI antimicrobial susceptibility testing guidelines
VET03-A and VET04-A2.
Date/Time:
November 18, 2014
1:002:00 PM Eastern (US) Time
Speaker:
Jim Pierson-Perry
Date/Time:
November 20, 2014
1:002:00 PM Eastern (US) Time
Speaker:
Sherry A. Dunbar, PhD
Luminex Corporation
Austin, Texas, USA
Date/Time:
December 4, 2014
1:002:00 PM Eastern (US) Time
Speakers:
Thomas L. Williams, MD, FACB,
FASCP, FCA
Nebraska Methodist Hospital
Omaha, Nebraska, USA
Earn P.A.C.E.
Each participant will receive P.A.C.E. Program CE credits for each webinar.
ORDER TODAY: TollToFree
(US):
877.447.1888
| www.clsi.org | customerservice@clsi.org 23
CE Credits!
learn more
or to
register today, visit www.clsi.org/webinars.
Date/Time:
December 10, 2014
1:002:00 PM Eastern (US) Time
Speaker:
Jean B. Patel, PhD, D(ABMM)
Centers for Disease Control
and Prevention
Atlanta, Georgia, USA
Dates/Times:
February 4, 2015
1:002:30 PM Eastern (US) Time
February 5, 2015
3:004:30 PM Eastern (US) Time
Speaker:
Janet A. Hindler, MCLS, MT(ASCP)
UCLA Health System
Los Angeles, California, USA
Unable to attend one of these webinars? Watch CLSI webinars on demand at your
convenience. Visit www.clsi.org/webinars/on-demand for a complete listing.
Prices range from $99 to $195 per site. CLSI member discount is available for CLSI-only webinars.
Earn P.A.C.E.
Each participant will receive P.A.C.E. Program CE credits for each webinar.
ORDER TODAY: TollToFree
(US):
877.447.1888
| www.clsi.org | customerservice@clsi.org 24
CE Credits!
learn more
or to
register today, visit www.clsi.org/webinars.
City:
Zip/Postal Code:
Country:
Telephone:
E-mail:
Fax:
QTY
City:
Zip/Postal Code:
Country:
Telephone:
E-mail:
Fax:
Item Code
State/Province:
Theres never been a better time to join CLSI. Become an integral part of improving
global clinical laboratory testing and advancing the quality of patient care.
Title
Price
Total
membership application
order form
Membership Application
Name
Title
E-mail
# Copies
1-3
Full Price
39
5% Discount
1024
10% Discount
2599
15% Discount
100499
20% Discount
500+
25% Discount
International Express
1-3 day delivery
Add 35% (min. $40)
Country
Phone Number
Total
2-Day
Overnight
Early
Morning
13 Documents
$11
$16
$23
46 Documents
$14
$19
$26
710 Documents
$16
$21
$28
Specialty
Collections
$16
$21
$28
52
Address
Organization
Subtotal
Mastercard
VISA
AMEX
Card Number
Expiration Date (MM/YY):
Purchase order MUST be faxed or mailed.
Mail to:
Clinical and Laboratory Standards Institute
950 West Valley Road, Suite 2500
Wayne, PA 19087 USA
Wire Transfer
Fax Number
Website
Membership Category:
Desired Level:
I ($25,000)
I ($5,000)
II ($1,500)
III ($400)
I ($5,000)
II ($1,500)
III ($400)
Mail to:
Questions?
Fax to:
E-mail to:
610.688.0700
membership@clsi.org
610.688.0100.
Contact customerservice@clsi.org.
53
R E CE I V E
10% OFF
FALL UPDATE ITEMS
USING PROMO CODE
FA L L2014
OFFER ENDS DECEMBER 31, 2014
(Excludes Subscription Products and Webinars Co-hosted by APHL)